How Has the Robotic Cardiology Surgery Market Evolved Historically and What is its Current Size?
The robotic cardiology surgery market has seen considerable growth due to a variety of factors.
• The market for robotic cardiology surgery has seen rapid expansion in recent years. Its size is forecasted to increase from $0.72 billion in 2024 to $0.84 billion in 2025, noting a compound annual growth rate (CAGR) of 16.7%.
Factors contributing to this past growth include the increasing usage of robotic surgery in the field of cardiology, a looming preference for surgical procedures that are minimally invasive, the escalating occurrence of cardiovascular diseases as well as rising healthcare expenditures and an aging population.
What Does Future Hold for The Robotic Cardiology Surgery Market By 2029?
The robotic cardiology surgery market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size of robotic cardiology surgery is poised to witness a swift expansion. It is projected to reach $1.54 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 16.5%.
This predicted growth during the forecast duration can be related to the swelling investments in cutting-edge medical technologies, escalating telemedicine and remote surgeries, increasing surgical procedures, rising incidences of chronic diseases, supportive regulations, and the presence of reimbursement policies. Prominent avenues for growth identified for the forecast period include the incorporation of artificial intelligence (AI) and machine learning algorithms, innovative developments in robotic technology, downsizing of robotic components, pioneering product ideas, integration of 3D visualization, as well as inclusion of capabilities like motion scaling and tremor filtering.
What Are The Primary Growth Drivers In The Robotic Cardiology Surgery Market?
The escalating occurrence of heart-related diseases is anticipated to accelerate the growth trajectory of the robotic cardiology surgery market. These cardiovascular diseases, implicated with the heart or blood vessels, are increasing due to an amalgamation of factors such as lifestyle habits, medical conditions, inherited tendencies, and environmental elements. Robotic cardiology surgeries are instrumental in revolutionizing the medical response to cardiovascular diseases; offering safer, more exact, and less intrusive surgery options, culminating in improved patient results and excellent care quality. To illustrate, data from the Australian Institute of Health and Welfare, a government agency based in Australia, indicated that in December 2023, medically certified deaths caused by Coronary Heart Disease (CHD) increased from 14,100 in 2021 to 14,900 in 2022. Consequently, the surge in cardiovascular diseases is the driving force for the robotic cardiology surgery market's growth.
What Is The Segmentation Of The Global Robotic Cardiology Surgery Market?
The robotic cardiology surgery market covered in this report is segmented –
1) By Product And Service: Robotic Systems, Instruments and Accessories, Maintenance Services, System Services
2) By Equipment Type: Robot Machines, Navigation Systems, Planners And Simulators, Other Equipment Types
3) By End-User: Hospitals, Research Centers
Subsegments:
1) By Robotic Systems: Robotic Surgical Platforms, Minimally Invasive Robotic Systems, Integrated Robotic Systems
2) By Instruments And Accessories: Surgical Instruments, Endoscopic Cameras And Imaging Systems, Accessory Kits For Robotic Systems
3) By Maintenance Services: Preventive Maintenance Services, Repair And Replacement Services, Calibration Services
4) By System Services: Installation and Setup Services, Training And Support Services, Upgrades And Software Maintenance
Pre-Book The Robotic Cardiology Surgery Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Robotic Cardiology Surgery Market?
Leading corporations in the robotic cardiology surgery market are devoting their efforts to create groundbreaking surgical solutions like assistive robotic devices (ARD) to increase accuracy in cardiac procedures, lessen invasiveness, and elevate patient results through the use of modern technology and live data analysis. The term "Assistive Robotic Devices (ARD)" pertains to robotic systems engineered to assist people with disabilities or limited movement, supporting them with everyday tasks such as relocation, communication, or routine activities. These devices positively affect users' autonomy and enhance their lifestyle quality. For example, CardioPrecision Ltd., a UK-based firm specializing in robotic surgeries, introduced proof-of-concept robotic processes in March 2024. These processes are planned for the implantation of an aortic valve replacement using a minimally invasive method, following successful experiments on cadaver models. The implemented robotic system heightens precision and control throughout the operation, enabling surgeons to execute their operations with enhanced exactness and possibly augmenting the procedure's overall success rate. This reduction of invasiveness is remarkable as it can diminish pain, lessen blood loss, and lower the risk of infection, ultimately expediting the patient's recovery time.
Who Are the Key Players In The Robotic Cardiology Surgery Market?
Major companies operating in the robotic cardiology surgery market are:
• Abbott Laboratories
• Medtronic PLC
• Siemens Healthineers AG
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Smith & Nephew PLC
• KARL STORZ SE & Co. KG
• Renishaw PLC
• Think Surgical Inc.
• Terumo Corporation
• CMR Surgical limited
• Corindus Vascular Robotics Inc.
• XACT Robotics Ltd.
• Titan Medical Inc.
• Asensus Surgical Inc.
• Intuitive Surgical Inc.
• Aurora Surgical Robotics Inc.
• Precision Robotics Ltd.
• SS Innovations International Inc.
• Hansen Medical Inc.
What Are The Regional Insights Into The Robotic Cardiology Surgery Market?
North America was the largest region in the robotic cardiology surgery market in 2024. The regions covered in the robotic cardiology surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
